Ancora Advisors
BMRN icon

Ancora Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History

Ancora Advisors’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-702
Closed -$41.7K – 2417
2025
Q4 		$41.7K Sell
702
-216
-24% -$11.8K ﹤0.01% 1207
2025
Q3 		$49.7K Hold
918
– – ﹤0.01% 1035
2025
Q2 		$50.5K Sell
918
-75
-8% -$4.42K ﹤0.01% 1020
2025
Q1 		$70.2K Sell
993
-300
-23% -$20.2K ﹤0.01% 935
2024
Q4 		$85K Sell
1,293
-350
-21% -$23.4K ﹤0.01% 884
2024
Q3 		$115K Sell
1,643
-150
-8% -$12.5K ﹤0.01% 792
2024
Q2 		$148K Hold
1,793
– – ﹤0.01% 734
2024
Q1 		$157K Buy
1,793
+43
+2% +$3.85K ﹤0.01% 724
2023
Q4 		$169K Sell
1,750
-150
-8% -$13.3K ﹤0.01% 706
2023
Q3 		$168K Hold
1,900
– – ﹤0.01% 694
2023
Q2 		$165K Hold
1,900
– – ﹤0.01% 689
2023
Q1 		$185K Hold
1,900
– – 0.01% 664
2022
Q4 		$197K Sell
1,900
-200
-10% -$18.8K 0.01% 673
2022
Q3 		$178K Sell
2,100
-25
-1% -$2.23K 0.01% 759
2022
Q2 		$176K Sell
2,125
-91
-4% -$7.25K 0.01% 795
2022
Q1 		$171K Sell
2,216
-125
-5% -$10.5K ﹤0.01% 845
2021
Q4 		$207K Buy
2,341
+1,916
+451% +$158K ﹤0.01% 791
2021
Q3 		$33K Buy
425
+350
+467% +$27.6K ﹤0.01% 1317
2021
Q2 		$6K Hold
75
– – ﹤0.01% 1646
2021
Q1 		$6K Hold
75
– – ﹤0.01% 1522
2020
Q4 		$7K Sell
75
-200
-73% -$15.9K ﹤0.01% 1248
2020
Q3 		$21K Hold
275
– – ﹤0.01% 1007
2020
Q2 		$34K Hold
275
– – ﹤0.01% 894
2020
Q1 		$23K Buy
+275
New +$23.7K ﹤0.01% 1026

Other funds holding BMRN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ancora Advisors's BMRN Position: Q1 2026 in Review

Ancora Advisors sold out of BioMarin Pharmaceuticals (BMRN) in Q1 2026, closing a stake of 702 shares — an estimated $41.7K sold.

Ancora Advisors first reported a position in BMRN in Q1 2020 and held it in 24 quarters. The position peaked at $207K in Q4 2021. 559 funds tracked by Wall St. Rank hold BMRN as of Q1 2026.

  • Ancora Advisors reported no remaining BioMarin Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Ancora Advisors sold 702 BioMarin Pharmaceuticals shares in Q1 2026, an estimated $41.7K.
  • Ancora Advisors first reported a position in BioMarin Pharmaceuticals in Q1 2020 and held it in 24 quarters.
  • Ancora Advisors's BioMarin Pharmaceuticals position peaked at $207K in Q4 2021.
  • 559 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q1 2026.

Based on Ancora Advisors's 13F filing for Q1 2026, filed 15 May 2026.